In a significant move that signals a new phase of growth for the sleep management sector, Persante Health Care has officially announced the appointment of Bretton Lane, BS, RPSGT, as its new President and Chief Growth Officer. Lane, a seasoned veteran of the sleep diagnostics and virtual care landscape, joins the organization at a pivotal moment, tasked with scaling home sleep testing (HST) infrastructure and spearheading the integration of emerging technologies into the company’s national service model.
The appointment comes as Persante—already one of the largest sleep management providers in the United States—seeks to solidify its footprint across hospitals, health systems, physician practices, and specialized sleep centers. By bringing on a leader with Lane’s specific background in rapid organizational scaling and multi-modal care delivery, Persante is clearly positioning itself to capitalize on the increasing decentralization of sleep medicine.
Main Facts: A High-Stakes Transition
The core of this executive transition centers on the merger of Persante’s established clinical infrastructure with Lane’s operational expertise. As the healthcare industry pivots toward home-based monitoring and remote patient management, Persante is doubling down on its commitment to bridge the gap between traditional laboratory diagnostics and the modern, patient-centered digital health experience.
Key components of Lane’s new mandate include:
- Expansion of Home Sleep Testing (HST): Streamlining the logistics and clinical oversight of home-based diagnostics to meet surging demand.
- Technological Evaluation: Serving as a primary architect for the vetting and implementation of new diagnostic technologies and digital health platforms.
- Strategic Growth: Leveraging existing partnerships with health systems to introduce new service lines that improve patient outcomes and operational efficiency.
- Clinical Excellence: Ensuring that rapid growth does not come at the expense of regulatory compliance, patient data privacy, or the high standard of clinical care that is the hallmark of the Persante brand.
Chronology: The Path to Leadership
Bretton Lane’s ascent to the presidency of Persante is underscored by a track record of high-impact leadership, most notably her recent tenure at BetterNight. Her career path reflects a deep, ground-up understanding of the clinical and operational nuances required to manage large-scale sleep health networks.
The BetterNight Years (2015–2024)
Lane’s time at BetterNight was defined by aggressive, sustainable growth. When she joined the organization, it functioned as a smaller enterprise; by the time of her departure, the company had blossomed into a national powerhouse with a workforce of approximately 450 employees.
During her tenure, Lane was instrumental in diversifying the company’s service portfolio. Her oversight included:
- Virtual Care Integration: Developing platforms that allowed for remote consultations, reducing the physical burden on patients while increasing provider capacity.
- Durable Medical Equipment (DME) Optimization: Managing the complexities of sleep-related equipment procurement and patient adherence programs.
- Population Health Initiatives: Moving beyond one-off diagnostic tests to long-term chronic disease management strategies, particularly for obstructive sleep apnea (OSA).
The Transition to Persante
Following her successful tenure at BetterNight, Lane spent time evaluating the next frontier of sleep medicine. Her decision to join Persante was characterized by a focus on "organizational foundation." As she noted in recent communications, the decision to join the firm was predicated on the company’s existing scale and its readiness to innovate at the intersection of clinical care and technological advancement.
Supporting Data: The Current State of the Sleep Market
The demand for sleep health services is at an all-time high, driven by an aging population, rising obesity rates, and an increased awareness of the systemic health risks associated with sleep disorders, such as cardiovascular disease, diabetes, and cognitive decline.
Recent industry data suggests that:
- Shift to Home Testing: The home sleep testing market is expected to grow at a CAGR of over 7% through 2030, as patients increasingly prefer the comfort and convenience of home-based monitoring over traditional overnight laboratory stays.
- Health System Partnerships: Hospitals are increasingly outsourcing their sleep laboratories to specialized firms like Persante to reduce overhead, ensure high-quality billing compliance, and manage the complex logistics of patient follow-up care.
- The Digital Health Surge: The "Digital Front Door" in healthcare has become a necessity. Providers are now expected to offer seamless, app-based communication, remote CPAP monitoring, and telehealth follow-ups—all areas where Lane has demonstrated prior expertise.
Persante’s decision to appoint a leader with deep knowledge in both clinical diagnostics (RPSGT) and business operations suggests a strategic shift toward a "full-lifecycle" care model, where the organization supports the patient from the initial diagnostic test through long-term therapy adherence.
Official Responses and Strategic Vision
The leadership at Persante has framed this appointment as a validation of the company’s current trajectory. Vyto Kab, CEO of Persante, highlighted the necessity of bringing in top-tier talent to maintain the company’s competitive advantage.
"We’re excited to welcome Bretton to Persante," Kab stated in the official announcement. "She brings exceptional industry knowledge, proven leadership, and a passion for advancing sleep medicine. Bretton is joining an already exceptional management team, and we’re confident her experience will strengthen our organization, support our partners, and help build on the momentum we’ve created."
For her part, Lane emphasized the cultural and strategic alignment between her professional values and Persante’s organizational mission. "Choosing the right opportunity mattered, and that’s why Persante stood out," Lane noted. "Joining one of the largest sleep management companies in the country, with a strong foundation, an exceptional team, and a clear vision for the future, made this an exciting next step in my career. With so much happening across the sleep industry, Persante is uniquely positioned to help shape what’s next, and I’m excited to be part of that journey."
Implications: What This Means for the Industry
The arrival of Bretton Lane at Persante serves as a bellwether for the broader sleep medicine industry. Several key implications emerge from this move:
1. The Professionalization of Sleep Management
As sleep medicine matures, the companies dominating the space are moving away from simple service-provider models toward comprehensive population health management. By hiring an executive with a background in virtual care and population health, Persante is signaling that it intends to compete on outcomes, not just volume.
2. Regulatory and Compliance Focus
With the healthcare sector facing increasing scrutiny regarding patient privacy and billing practices—particularly in the realm of virtual care and DME—Lane’s mandate to reinforce "regulatory compliance and patient privacy" is a timely strategic move. As federal regulators continue to monitor the telehealth landscape, having an experienced executive who understands the nuances of multi-state operations will be a significant asset for Persante.
3. Accelerated Adoption of AI and Diagnostic Tech
The mention of "evaluating emerging technologies" is perhaps the most significant indicator of Persante’s future roadmap. Artificial Intelligence is currently transforming sleep medicine, from automated scoring of polysomnograms (PSG) to predictive modeling for patient adherence. Lane’s role will likely involve vetting these tools to determine which innovations offer the highest ROI in terms of both clinical outcome and operational cost-saving.
4. Competitive Pressure on Smaller Labs
For smaller, independent sleep labs, the consolidation of the market and the rise of firms like Persante—now bolstered by high-level executive talent—poses a challenge. The economies of scale achieved by national organizations, combined with their ability to implement sophisticated, tech-enabled care models, may force smaller players to seek acquisition or strategic partnerships to remain relevant.
Conclusion: A New Chapter
The appointment of Bretton Lane to the role of President and Chief Growth Officer is more than just a personnel update; it is a declaration of intent. Persante Health Care is signaling that it intends to be the primary driver of innovation in the national sleep medicine market.
By marrying Lane’s proven ability to scale operations with Persante’s robust infrastructure, the company is positioning itself to handle the dual challenges of increasing patient volume and the rapid technological disruption of the diagnostic field. As the industry continues to move toward a more integrated, patient-centric model of sleep health, all eyes will be on Persante to see how these new leadership initiatives translate into tangible improvements in patient care and market share.
With a focus on clinical excellence, strategic partnership development, and the adoption of cutting-edge technology, Persante is not merely participating in the evolution of sleep medicine—it is attempting to define it.
